Cucumis melo ssp. Agrestis var. Agrestis Ameliorates High Fat Diet Induced Dyslipidemia in Syrian Golden Hamsters and Inhibits Adipogenesis in 3T3-L1 Adipocytes

Articles

Abstract
Pharmacognosy Magazine,2015,11,44s3,s501-s510.
Published:December 2015
Type:Original Article
Authors:
Author(s) affiliations:

Kripa Shankar1, Sumit K Singh2, Durgesh Kumar3, Salil Varshney1, Abhishek Gupta1, Sujith Rajan3, Ankita Srivastava3, Muheeb Beg1, Anurag Kumar Srivastava4, Sanjeev Kanojiya5, Dipak K Mishra6, Anil N Gaikwad1
1 Division of Pharmacology, CSIR Central Drug Research Institute, Lucknow, Uttar Pradesh, India
2 Division of Botany, CSIR Central Drug Research Institute, Lucknow, Uttar Pradesh, India
3 Division of Pharmacology, CSIR Central Drug Research Institute; Academy of Scientific and Innovative Research, CSIR Central Drug Research Institute, Lucknow, Uttar Pradesh, India
4 Division of Toxicology, CSIR Central Drug Research Institute, Lucknow, Uttar Pradesh, India
5 Sophisticated Analytical Instrument Facility, CSIR Central Drug Research Institute, Lucknow, Uttar Pradesh, India
6 Division of Botany, CSIR Central Drug Research Institute; Division of Pharmacology, CSIR Central Drug Research Institute, Lucknow, Uttar Pradesh, India

Abstract:

Background: Cucumis melo ssp. agrestis var. agrestis (CMA) is a wild variety of C. melo. This study aimed to explore anti-dyslipidemic and anti-adipogenic potential of CMA. Materials and Methods: For initial anti-dyslipidemic and antihyperglycemic potential of CMA fruit extract (CMFE), male Syrian golden hamsters were fed a chow or high-fat diet with or without CMFE (100 mg/kg). Further, we did fractionation of this CMFE into two fractions namely; CMA water fraction (CMWF) and CMA hexane fraction (CMHF). Phytochemical screening was done with liquid chromatography-mass spectrometry LC- (MS)/MS and direct analysis in real time-MS to detect active compounds in the fractions. Further, high-fat diet fed dyslipidemic hamsters were treated with CMWF and CMHF at 50 mg/kg for 7 days. Results: Oral administration of CMFE and both fractions (CMWF and CMHF) reduced the total cholesterol, triglycerides, low‐density lipoprotein cholesterol, and very low‐density lipoprotein-cholesterol levels in high fat diet-fed dyslipidemic hamsters. CMHF also modulated expression of genes involved in lipogenesis, lipid metabolism, and reverse cholesterol transport. Standard biochemical diagnostic tests suggested that neither of fractions causes any toxicity to hamster liver or kidneys. CMFE and CMHF also decreased oil-red-O accumulation in 3T3-L1 adipocytes. Conclusion: Based on these results, it is concluded that CMA possesses anti-dyslipidemic and anti-hyperglycemic activity along with the anti-adipogenic activity.

PDF
Keywords